Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Molecular Biology|September 15, 1998
Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrasesS Maignan, J P Guilloteau, Q Zhou-Liu, et al.Science (New York, N.Y.)|April 14, 1995
Crystal structure of the mammalian Grb2 adaptorS Maignan, J P Guilloteau, N Fromage, et al.Journal of Molecular Biology|January 20, 1993
Crystallization and preliminary X-ray diffraction studies of beta-cryptogein, a toxic elicitin secreted by the phytopathogenic fungus Phytophthora cryptogeaJ P Guilloteau, C Nespoulous, J C Huet, et al.Acta Crystallographica. Section B, Structural Science|August 1, 1992
Structure determination of a dimeric form of erabutoxin-b, crystallized from a thiocyanate solutionP Saludjian, T Prangé, J Navaza, et al.Protein Expression and Purification|October 26, 2000
Large-scale expression, refolding, and purification of the catalytic domain of human macrophage metalloelastase (MMP-12) in Escherichia coliA A Parkar, M D Stow, K Smith, et al.Proteins|May 1, 1996
Purification, stabilization, and crystallization of a modular protein: Grb2J P Guilloteau, N Fromage, M Ries-Kautt, et al.Journal of Medicinal Chemistry|September 1, 2000
Crystal structures of human factor Xa complexed with potent inhibitorsS Maignan, J P Guilloteau, S Pouzieux, et al.Journal of Medicinal Chemistry|September 10, 1999
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor XaW R Ewing, M R Becker, V E Manetta, et al.Journal of Medicinal Chemistry|September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimizationY M Choi-Sledeski, D G McGarry, D M Green, et al.Pageof 1